Login to Your Account



Clinic Roundup


Thursday, November 7, 2013
Supernus Pharmaceuticals Inc., of Rockville, Md., said that in a single-blind, randomized-sequence, crossover study in healthy adults, Trokendi (SPN-538), produced more consistent plasma concentrations of topiramate compared to topiramate.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription